ASX
Mesoblast Limited
MSB:ASX•Healthcare
Sensitive ASX Announcement
Mesoblast to Evaluate Remestemcel-L in COVID-19 Lung Disease
Published: 10/03/20, 09:50am (AEST)•3 pages